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ABSTRACT 
Androgen Regulation of Insulin Signaling in 3T3-L1 Induced Adipocytes 
 
Briana Bryson 
Department of Animal Science 
Texas A & M University 
 
Research Advisor: Dr. Annie Newell-Fugate 
Department of Veterinary Physiology and Pharmacology 
 
Polycystic ovary syndrome (PCOS), the most common endocrine disorder of reproductive age 
women, affects obese women disproportionately.1 This syndrome is characterized by 
hyperandrogenemia, cystic ovaries, and/or oligo/anovulation.2 Hyperandrogenic conditions 
such as PCOS are often associated with insulin resistance and hyperinsulinemia, particularly 
in obese women.3 However, it is unknown whether excess androgens play a direct role in the 
promotion of insulin resistance in obese females. We hypothesize androgens, independent 
from obesity, cause disruption of insulin signaling in adipocytes at the level of the androgen 
receptor (AR). Using the murine 3T3-L1 pre-adipocyte cell line, we assessed the effects of 
dihydrotestosterone (DHT; 10-6 M), a potent, non-aromatizable androgen, on insulin signaling 
in induced adipocytes. Identification of the role androgens may play in adipocyte insulin 
signaling will help elucidate the relationship between hyperandrogenemia and 
hyperinsulinemia and may provide a foundation for the development of new pharmaceuticals 
designed to target both hyperinsulinemia and hyperandrogenemia in obese female patients. 
We assessed mRNA transcript expression of forkhead box A1 (FOXA1), forkhead box O1 
(FOXO1), insulin receptor (INSR), and  protein kinase B isoform 2 (Akt2) relative to 
glyceraldehyde phosphate dehydrogenase (GAPDH) in cultured adipocytes and glucose 
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present in cell culture media to determine how DHT may affect the insulin signaling in 3T3-
L1 induced adipocytes. Our data revealed no significant difference in mRNA transcript 
expression of FOXO1, INSR, and Akt2 relative to GAPDH in control and DHT-treated 3T3-
L1 induced adipocytes, and we found that FOXA1 could not be detected. Additionally, there 
was no significant difference in media glucose concentrations collected from wells containing 
DHT-treated and control 3T3-L1 induced adipocytes. While it is possible DHT does not alter 
insulin signaling in 3T3-L1 induced adipocytes, it recommended that additional replications 
of this experiment be completed in order to increase the statistical power. 
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NOMENCLATURE 
 
Akt   Protein Kinase B 
Akt2   Protein Kinase B Isoform 2 
ANOVA  Analysis of Variance 
AR   Androgen Receptor 
ATCC   American Type Culture Collection 
DEPC   Diethylpyrocarbonate 
DHT   Dihydrotestosterone 
DMEM  Dulbecco’s Modified Eagle Medium 
DMSO   Dimethyl Sulfoxide 
FBS   Fetal Bovine Serum 
foxa1   Forkhead Box A1 
foxo2   Forkhead Box O2 
GAPDH  Glyceraldehyde Phosphate Dehydrogenase 
GLUT4  Glucose Transporter 4 
HRP   Horseradish Peroxidase Concentrate 
IBMX   3-isobutyl-1-methylxanthine 
INSR   Insulin Receptor 
IRS1   Insulin Receptor Substrate 1 
IRS2   Insulin Receptor Substrate 2 
LSM   Least Squares Mean 
PCOS   Polycystic Ovary Syndrome 
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PKB   Protein Kinase B 
PKCɛ   Protein Kinase C Epsilon Type 
PPAP2A  Phosphatidic Acid Phosphatase 2a 
qPCR   Quantitative Polymerase Chain Reaction 
RIPA   Radioimmunoprecipitation Assay 
RNA   Ribonucleic Acid 
SEM   Standard Error of the Mean 
TC   Tissue Culture 
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SECTION I  
INTRODUCTION 
 
Up to 70 % of Americans are overweight or obese, and the age-adjusted rate of obesity in 
women is nearly 35 %.4 In women, increased visceral fat deposition, insulin resistance, 
glucose intolerance, and type II diabetes are all closely associated with polycystic ovary 
syndrome.3 PCOS,  characterized by hyperandrogenism, chronic oligo/anovulation and/or 
ovarian cysts, affects about 1 in 10 women of reproductive age.1 Obese women represent 50 to 
70 percent of PCOS cases5, and tend to express more aggravated symptoms of the disorder.1 
Hyperinsulinemia, though not considered a defining symptom of PCOS, is also closely 
associated with the disorder and more pronounced in obese patients.6 Whether excess 
androgens play a role in the promotion of insulin resistance in obese females is unknown. 
Available treatment options for PCOS are inefficient in that they target the various symptoms 
rather than the syndrome itself.6 Determining the effect of androgens on insulin signaling in 
obese females is critical in order to facilitate development of novel pharmaceuticals to 
simultaneously treat both insulin resistance and hyperandrogenism in obese females. 
 
Most of the research performed thus far on the role of androgens in insulin signaling pathways 
has focused on men, particularly in the area of prostate cancer. A study using prostate cells 
showed that stimulation of the androgen receptor (AR) via removal of the AR repressor 
protein, forkhead box O1 (foxo1), from the nucleus leads to increased insulin signaling.5 
However, the role of androgens in glucose homeostasis is sexually dimorphic, with insulin 
resistance occurring in females with elevated serum androgen levels but in males with 
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decreased serum androgen levels.3 A single study in lean women found that in-vitro treatment 
of differentiated primary pre-adipocytes with testosterone caused insulin resistance via 
insulin-stimulated phosphorylation of protein kinase C ζ, which glucose into the cell via the 
glucose transporter type 4 (GLUT4) transporter.9 The pathway by which androgens may 
mediate this insulin resistance in adipocytes of lean females and whether the same response is 
seen in the adipocytes of obese females are unknown. 
 
Foxo1 and forkhead box A1 (foxa1) are regulators of adipocyte metabolism located 
downstream of the insulin receptor10, and function as co-regulators of classical, nuclear AR 
action11.  Foxo1, an inhibitor of AR transcriptional activity, is phosphorylated downstream of 
insulin receptor substrate 2 (IRS2) in the insulin signaling pathway, whereas foxa1, an 
activator of AR transcriptional activity, is phosphorylated downstream of both insulin receptor 
substrate 1 (IRS1) and IRS212. The function of the forkhead box family of proteins is 
modulated through phosphorylation by protein kinase B (Akt) among other kinases13. In 
preliminary studies conducted in the Newell-Fugate lab, it was found that testosterone 
administration to intact, lean female pigs over a course of 14 days resulted in down-regulation 
of phosphorylated Akt, a member of the insulin signaling pathway, in visceral but not in 
subcutaneous fat. This discovery suggests that androgens themselves may play a role in the 
promotion of insulin resistance in females.  
 
The objective of this research is to identify whether androgens regulate insulin signaling in 
induced murine 3T3-L1 adipocytes. The central hypothesis is that androgens, independent 
from obesity, cause disruption of insulin signaling in adipocytes at the level of the AR. 
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Specifically, we hypothesize that androgens down-regulate the insulin signaling pathway 
directly via classical stimulation of the genomic AR and cause decreased glucose uptake in 
adipocytes. This central hypothesis will be tested, and the objective obtained, by examination 
of one specific aim: Assessment of the effects of androgens on insulin signaling and glucose 
uptake in induced murine 3T3-L1 adipocytes.  
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SECTION II 
METHODS 
 
A. Cell culture  
3T3-L1 pre-adipocytes (ATCC, Manassas, VA) were seeded onto 100x20 mm tissue culture 
(TC)-treated dishes (Costar, Corning, Corning, NY) with DMEM/F12 (Gibco, Invitrogen, 
Carlsbad, CA) base medium containing 10% FBS (VWR, Radnor, PA) and 1% 
antibacterial/antifungal cocktail (100x Anti-Anti, Gibco, Invitrogen). The 3T3-L1 pre-
adipocytes were grown to about 70% confluency, and were then passaged at a density of 
70,000 live cells/well in two TC-treated 6-well plates (Costar, Corning) and two 60x20 mm 
TC-treated dishes (Costar, Corning), and grown to 100% confluency. Forty eight hours after 
the cells reached confluency and became over-confluent, they were treated for 48 hours with 
adipocyte differentiation medium, composed of DMEM/F12 base medium with 1.0 μM 
dexamethasone (G-biosciences, St. Louis, MO), 0.5 mM IBMX (Sigma-Aldrich, St. Louis, 
MO), and 1.0 μg/mL insulin (Sigma-Aldrich). Following the treatment with adipocyte 
differentiation medium, cells were treated with adipocyte maintenance medium, composed of 
DMEM/F12 base medium with 1.0 μg/mL insulin, for seven days or until they were 60- 80 % 
differentiated into adipocytes. Differentiation was assessed qualitatively by staining the two 
dishes with Oil Red O (Sigma-Aldrich) and Mayer’s hematoxylin (Electron Microscopy 
Sciences, Hatfield, PA). Cells were then treated for 48 hours with either control ethanol 
(Koptec, Decon Labs, King of Prussia, PA) vehicle or DHT (10-6 M in ethanol vehicle; 
Steraloids, Newport, RI) in adipocyte maintenance media. Treatments were administered in 
duplicate or triplicate for technical replication. After 48 hours, the media from each well was 
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collected. Cells from Plate 1 were lysed with 950 μL 10X RIPA lysis buffer (Cell Signaling 
Technologies, Boston, MA) for protein extraction. Cells from Plate 2 were lysed with 1 mL 
TRIzol reagent (Invitrogen) for mRNA extraction. The media and contents of each lysate were 
stored in a 1.5 mL DNase/RNase free snap cap tube (Fisherbrand, Hampshire, NH) at -80°C 
until further analysis. 
 
B. RNA extraction and quantitation, cDNA synthesis, protein quantitation, and real time 
PCR 
Two hundred microliters of chloroform was added to each of the TRIzol-treated lysates, 
which were then vortexed, and centrifuged at 12,000 g for 15 minutes at 4°C. The upper 
aqueous phase was transferred into new DNase/RNase free snap cap tubes, and 0.5 mL of 
isopropyl alcohol were added to the tubes in order to precipitate the RNA. The tubes were 
centrifuged at 12,000 g for 10 minutes at 4°C, and after removing the supernatant, the pellets 
were washed with 1 mL of 75% ethanol. The samples were then centrifuged at 7,500 g or 5 
minutes at 4°C. After removing excess ethanol, the RNA pellets were allowed to dry for 10 
minutes before being dissolved in 10 μL of water treated with DEPC (Sigma-Aldrich). After 
incubating the samples on a 55°C heat block, they were stored in the -80 freezer for later use. 
Isolated RNA was diluted 1:1000 using 1 μL of the concentrated RNA pellets and 999 μL of 
DEPC-treated water. After creating a calibration curve using two pre-prepared standards, 1 μL 
of the RNA dilutions and 199 μL of Qubit working solution (Invitrogen) were mixed and ran 
on the Qubit 3.0 Fluorometer in order to determine RNA concentration. Protein concentration 
was determined by diluting protein samples 1:25 using DEPC-treated water and running the 
samples on a Qubit 3.0 Fluorometer using a Qubit Protein Assay Kit (Invitrogen). Reverse 
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transcription was performed on the RNA in order to convert it into cDNA for PCR analysis, 
using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, 
CA) and an iCycler (Bio-Rad Laboratories, Hercules, CA) for temperature fluctuation. RNA 
transcript expression for forkhead box 1 (FOXO1), insulin receptor (INSR), and protein 
kinase B isoform 2 (Akt2) relative to housekeeping gene, glyceraldehyde phosphate 
dehydrogenase (GAPDH), was assessed using Taqman-based real time PCR.  
 
C. Glucose determination in media 
The amount of glucose (mg/dL) in the media from each well was determined using the 
Glucose Colorimetric Detection Kit (Arbor Asssays, Ann Arbor, MI). Media samples were 
thawed and diluted to a 1:10 ratio using PBS. Twenty microliters of each of the 7 glucose 
standards were pipetted into a 96 well plate (Costar, Corning). Twenty microliters of assay 
buffer, 25 μL of HRP solution, 25 μL of Calorimetric solution, and 25 μL of glucose oxidase 
concentrate solution were added to the wells following the addition of the glucose samples 
and standards. The solutions were incubated at room temperature for 30 minutes before being 
read with a BioTek Gen5 microplate reader at 560 nm.   
 
D. Statistical analysis 
All data was assessed for normality using PROC UNIVARIATE (SAS, Inc, Cary, NC).  Non-
normal variables were logarithmically transformed prior to comparison of treatments using 
un-paired Student’s T-test.  Results are displayed as least squares mean (LSM) ± standard 
deviation (SD). The level of significance was set at p=0.05.  
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SECTION III 
RESULTS 
 
A. Real time PCR Analysis: 
There was no significant difference in RNA transcript expression of FOXO1, INSR, and Akt2 
relative to GAPDH between control and DHT-treated 3T3-L1 induced adipocytes (p=0.9; 
Figure 2). FOXA1 was also assessed but was unable to be detected in any of the treated cells.  
 
 
 
 
 
 
B. Glucose Concentration in Cell Culture Media 
 i. RNA quantitation: 
 RNA content in control wells was 52.8 ng (C1) and 26.8 ng (C2), respectively. RNA 
content in DHT-treated wells were 50.9 ng (DHT1) and 42.4 ng (DHT2), respectively. 
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Figure 2. Relative RNA transcript expression in induced 3T3-L1 adipocytes after 48 
hours of treatment. RNA transcript expression of forkhead box 1 (FOXO1), insulin 
receptor (INSR), and protein kinase B isoform 2 (Akt2) relative to glyceraldehyde 
phosphate dehydrogenase (GAPDH). There was no difference (p=0.9) in the relative RNA 
transcript expression between control and DHT treated wells (n=4) for any of the genes 
assessed.  
13 
 
Glucose found in the cell culture media was standardized to RNA (ng) per well  
(C1=0.219 mg glucose/ng RNA;, C2=0.858 mg glucose/ng RNA); DHT1=0.517 mg 
glucose/ng RNA; DHT2=0.246 mg glucose/ng RNA). The control wells had 0.575 ± 
0.401 mg glucose/ ng RNA. The DHT-treated wells had an 0.381 ± 0.191 mg glucose/ 
ng RNA (Figure 1). There was no significant difference in the amount of glucose 
found in the media of control versus DHT treated wells when calculated using RNA 
quantity in the wells (p>0.601).  
 
ii. Protein quantitation:  
Protein content in control wells was 2700 μg (C3) and 1590 μg (C4), respectively. 
Protein content in DHT-treated wells were 2120 μg (DHT3) and 1630 μg (DHT4), 
respectively. Glucose found in the culture media was standardized to protein (μg) per 
well (C3=0.007 mg glucose/ μg protein; C4=0.036 mg glucose/ μg protein; 
DHT3=0.018 mg glucose/ μg protein; DHT4=0.032 mg glucose/ μg protein). The 
control wells had 0.022 ± 0.021 mg glucose/ μg protein. The DHT-treated wells had 
0.025 ± 0.010 mg glucose/ μg protein (Figure 1). There was no significant difference 
in the amount of glucose found in the media of control versus DHT-treated wells when 
calculated using protein quantity in the wells (p>0.849). 
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Figure 1. Glucose concentration in media from induced 3T3-L1 adipocytes 
after 48 hours of treatment. A. Glucose concentration (mg glucose/ng RNA) in 
control or DHT treated wells collected for PCR analysis (n=4). B. Glucose 
concentration (mg glucose/μg protein) in control or DHT treated wells collected 
for protein analysis (n=4). There was no difference (p>0.6) in glucose 
concentration between control and DHT treated wells for either experiment. 
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SECTION IV 
CONCLUSION 
 
The results of this study imply that further experimentation will be necessary in order to 
determine the role the androgen DHT has on insulin signaling in induced 3T3-L1 adipocytes. 
The addition of DHT did not alter the glucose concentration in the media of induced 3T3-L1 
adipocytes, as shown by the large p-values. There was also no difference in RNA transcript 
expression of FOXO1, INSR, Akt2 in induced 3T3-L1 adipocytes between control and DHT-
treated wells. We were unable to detect FOXA1, implying its role in regulating the androgen 
receptor in 3T3-L1 pre-adipocytes may be limited following differentiation.  
 
Although we did not detect differences between control and DHT treated wells in any 
parameter assessed, we only completed one replicate of the experiment and only a few 
technical replicates (i.e., treated wells) per treatment. Therefore, our power to detect 
differences between the treatments was very low. It is also possible that DHT does not alter 
insulin signaling in 3T3-L1 cells. It may prove useful to investigate ways to estimate the 
number of mature, live adipocytes in each well following differentiation in order to provide a 
more reliable measure of glucose concentration within the media. Oil Red O staining on its 
own only provided a crude estimate of the percentage of cells that successfully underwent 
differentiation, and could only account for the dishes stained. Additionally, protein analysis 
via western blotting would be helpful for evaluating the expression of proteins involved in the 
insulin signaling pathway. Further replication of the experiment to increase the power is 
recommended.  
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